New therapy for rare metabolic disorder Pompe disease approved by US FDA

被引：0
|
作者：
不详
机构：
来源：
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM | 2010年 / 5卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：479 / 479
页数：1
相关论文
共 50 条
  • [41] New FDA approved thyroid stimulating immunoglobulin assays for diagnosing and monitoring of Graves' disease - Fab or Fad?
    Hsieh, Albert
    McLennan, Susan V.
    Sherfan, Julie
    Brown, Marilyn
    Tan, Kris
    Woolnough, Catherine
    Hetherington, Julie
    Gargya, Ash
    Adelstein, Stephen
    Chua, Elizabeth L.
    Williams, Paul F.
    Twigg, Stephen M.
    CLINICAL ENDOCRINOLOGY, 2017, 86 : 21 - 21
  • [42] Cardiovascular and metabolic disease: new opportunities for therapy
    Vlasuk, GP
    Scarborough, RM
    CURRENT OPINION IN PHARMACOLOGY, 2005, 5 (02) : 119 - 121
  • [43] Ketone metabolic therapy to improve muscle function and coordination in a mouse model of infantile onset Pompe disease
    D'Agostino, Dominic P.
    Poff, Angela
    Deblasi, Janine M.
    Moss, Sara E.
    Thomas, Natalya
    MOLECULAR GENETICS AND METABOLISM, 2025, 144 (02) : 24 - 25
  • [44] LAPAROSCOPIC EXCISION OF AN URACHAL FISTULA - A NEW THERAPY FOR A RARE DISORDER
    NEUFANG, T
    LUDTKE, FE
    LEPSIEN, G
    MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES, 1992, 1 (03): : 245 - 249
  • [45] FDA BREAKTHROUGH THERAPY STATUS - A SYSTEMATIC ANALYSIS OF ALL THERAPIES APPROVED UNDER THIS NEW EXPEDITED APROVAL PATHWAY
    Macaulay, R.
    VALUE IN HEALTH, 2015, 18 (03) : A75 - A76
  • [46] Dercums Disease (Adiposis Dolorosa): Neuropsychological Features of a Rare Metabolic/Autoimmune Disorder
    Pimental, P.
    Frawley, J.
    Welch, M.
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2012, 27 (06) : 611 - 611
  • [47] WITHOUT FDA-APPROVED TESTOSTERONE TO TREAT WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER US PROVIDERS RELY ON OFF-LABEL PRESCRIBING
    Snabes, M. C.
    Milling, W.
    Simes, S. M.
    JOURNAL OF SEXUAL MEDICINE, 2011, 8 : 185 - 185
  • [48] A new frontier: FDA approvals for gene therapy in sickle cell disease
    Leonard, Alexis
    Tisdale, John F.
    MOLECULAR THERAPY, 2024, 32 (02) : 264 - 267
  • [49] Pyrukynd ushers in new era for rare cellular metabolic disease
    Charlotte Harrison
    Nature Biotechnology, 2022, 40 (4) : 446 - 448
  • [50] Pyrukynd ushers in new era for rare cellular metabolic disease
    Harrison, Charlotte
    NATURE BIOTECHNOLOGY, 2022, 40 (04) : 448 - 448
12345